In liver cancer cells, miR-200c is activated by nuclear receptors PPARα (peroxisome proliferator activated receptor alpha) and LRH-1 (liver receptor homolog-1), and is inhibited by SHP (small heterodimer partner), a transcriptional repressor that interacts with PPARα and LRH-1 [94]. This evidence concerns the gene NR5A2 and liver cancer.